• Live Meeting
  • Posters
  • Presenters
  • Industry Support
  • CME / PACE
79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing

79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing

by achatfield@ezav.biz | Jul 20, 2022 | 7 - Challenges in Genomic Testing

Marie-France Gagnon Marie-France Gagnon received her MD at the University of Montreal. Subsequently, she completed her Medicine residency and Hematology fellowship at the University of Montreal. She also holds a master’s degree in biomedical sciences focusing on the...
79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing

133. Incidental finding of the 1st degree of parental relatedness in a newborn with JBS and homozygous UBR1 mutation

by achatfield@ezav.biz | Jul 20, 2022 | 7 - Challenges in Genomic Testing

Jie Xu Jie Xu, PhD, is ABMGG certified in Clinical Cytogenetics and Genomics and Laboratory Genetics and Genomics. He is Medical Director, Cytogenetics at Akron Children’s Hospital (ACH) and Professor of Pathology, Northeast Ohio Medical University. He signs out...
  • 1 – Hematologic Malignancies
  • 2 – Solid Tumors
  • 3 – Genomic Resources for Variant Curation and Standardization
  • 4 – Technical Topics
  • 5 – Bioinformatics and Artificial Intelligence
  • 6 – Constitutional Disorders
  • 7 – Challenges in Genomic Testing
  • 8 – Other Oncology and Constitutional Topics

Powered by EZ Audio Visual